eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 02/07/2010
PIL Avandia tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/07/2010 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to Marketing Authorisation Holder
Updated on 16/06/2009 and displayed until 02/07/2010
Reasons for adding or updating:
  • Change of contra-indications
  • Change to side-effects
Updated on 20/06/2008 and displayed until 16/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 14/12/2007 and displayed until 20/06/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 10/07/2007 and displayed until 14/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to side-effects
Updated on 06/12/2006 and displayed until 10/07/2007
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 21/08/2006 and displayed until 06/12/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 24/04/2006 and displayed until 21/08/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  rosiglitazone